secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ernexa Therapeutics Inc. (ERNA)
CIK:        0000748592
Form:       8-K
Filed at:   2026-02-26T23:59:59+00:00
Accession:  0001493152-26-008182
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ernexa Therapeutics posts updated investor presentation on February 26, 2026
----------------------------------------------------------------------------

- Updated presentation replaces the December 11, 2025 version; available on company website.
- Presentation furnished under Item 7.01 Regulation FD; no financial statements or material agreements attached.
- Specific content of the update is not disclosed in the filing; investors should review the presentation directly.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/748592/000149315226008182/0001493152-26-008182-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/748592/000149315226008182/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-008182

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer